Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-includes/functions.php on line 6131

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-includes/functions.php on line 6131

Notice: Undefined offset: 0 in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-content/themes/cri/single.php on line 10

Notice: Trying to get property 'name' of non-object in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-content/themes/cri/single.php on line 10
Robert D. Schreiber, Ph.D. - Cancer Research Institute
stdClass Object ( [getLoginUrlResponse] => stdClass Object ( [JSESSIONID] => E49FF4C45F646AF34116DF5A1181283F.app30118b [routing_id] => 00000000.app30118b [url] => https://give.cancerresearch.org/site/CRConsAPI;jsessionid=00000000.app30118b?NONCE_TOKEN=21F8D772D5AF477AEC81BDCD4991055F [token] => 85FtRZLhyEi9i9iy4Da6xf7bCuFo8yK-BTYUhJ-_DuI1b14y4azL-6BGfgg5lN113OLYYIBJqP_rIDrDLU1OCcociG-mTVZxjdQW6H4 ) ) test
Scientific Advisory Council

Robert D. Schreiber, Ph.D.

Washington University School of Medicine

St. Louis, MO

Dr. Robert D. Schreiber is the director of the Center for Human Immunology and Immunotherapy Programs, and a professor in the Department of Molecular Microbiology at Washington University School of Medicine.

Dr. Schreiber has been a pivotal figure in validating and advancing the theory of cancer immunosurveillance and immunoediting, the processes by which our immune systems monitor, control, and shape the development of cancer. Among his honors, Dr. Schreiber has received the 2001 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology, the 2014 AACR-CRI Lloyd J. Old Award in Cancer Immunology, and the 2017 Balzan Prize. He has also been elected to the National Academy of Sciences and the American Association for the Advancement of Science. His current work continues to characterize how various immune signaling pathways, as well as tumor mutations, influence anti-tumor immune responses.

In addition to his role as an associate director of CRI’s Scientific Advisory Council, Dr. Schreiber is the chairman of the CLIP Grant Review Committee and serves on the Postdoctoral Fellowship Review Committee. He is also the editor-in-chief of the CRI/AACR journal Cancer Immunology Research, and is a lead investigator in CRI’s partnership with the Parker Institute for Cancer Immunotherapy, which seeks to develop neoantigen-based personalized cancer vaccines.

This site is registered on wpml.org as a development site.